Not So Different: A Podcast From The Center For Biosimilars
S4 Ep5: Sarfaraz Niazi, PhD Discusses Market Projections For High-Concentration Adalimumab Biosimilars
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:13:20
- Mas informaciones
Informações:
Sinopsis
To learn more about Celltrion's EU approval, click here. To learn more about Alvotech’s high concentration adalimumab, click here. To learn more about high-concentration citrate-free adalimumab products, click here. To learn about the patent dance, click here. For more in adalimumab news, click here or here.
